Acetyl Hexapeptide-3 (Argireline) 200mg

Acetyl Hexapeptide-3 — Proven Anti-Age Research Peptide 200mg

Acetyl hexapeptide-3 — also widely referenced as Argireline — is a synthetic hexapeptide engineered as a competitive inhibitor of SNAP-25 (synaptosome-associated protein 25 kDa). This compound has been extensively researched for its potential action in reducing wrinkle formation in skin tissue through modulation of neuromuscular signalling pathways. Supplied as a lyophilised powder in a single 200mg vial with a verified purity of >99%, this compound is formulated to the exacting standards required for in-vitro scientific research.

⚠️ Research Use Only. This product is intended exclusively for in-vitro scientific research. It is not approved for human or animal consumption, clinical use, or therapeutic application.

Table of Contents

1. Product Specifications
2. Molecular Mechanism — SNAP-25 Inhibition
3. SNARE Complex and Exocytosis Research Context
4. Research Applications
5. Reconstitution and Storage
6. FAQ

Product Specifications

Molecular Mechanism — SNAP-25 Inhibition

Acetyl hexapeptide 3 was developed as a competitive inhibitor of SNAP-25 — a 25 kDa synaptosome-associated protein that serves as an essential structural component of the SNARE complex.

The basis for this inhibitory activity lies in the structural similarity between the N-terminal amino acid sequence of SNAP-25 and the amino acid sequence of acetyl hexapeptide-3 itself. This sequence homology enables the peptide to compete with SNAP-25 for incorporation into the SNARE complex — effectively blocking the assembly of functional SNARE architecture.

The SNARE complex is a central regulator of synaptic vesicle exocytosis — the calcium-dependent release of signalling molecules at the neuromuscular junction. When SNARE complex formation is disrupted by competitive SNAP-25 inhibition, exocytosis is impaired, reducing the release of acetylcholine — the primary neurotransmitter mediating nerve-to-muscle communication and muscle contraction.

This mechanism is the molecular basis for the compound’s investigation in wrinkle formation research, where acetylcholine-mediated muscle contraction in facial tissue is associated with the progressive formation of expression lines.

SNARE Complex and Exocytosis Research Context

The SNARE (Soluble N-ethylmaleimide Sensitive Factor Attachment Protein Receptor) complex is one of the most extensively studied molecular machines in cell biology. Its role in vesicle docking, fusion and neurotransmitter release makes it a research target of broad significance across neuroscience, dermatology and cellular signalling research.

SNAP-25 is one of three core SNARE proteins — alongside syntaxin and VAMP/synaptobrevin — required for functional vesicle fusion. The selective inhibition of SNAP-25 through peptide competition represents a pharmacologically precise approach to modulating exocytosis without the systemic effects associated with other inhibitory mechanisms.

Acetyl hexapeptide-3’s selectivity for SNAP-25 has made it a research tool of interest not only in dermatological wrinkle biology but also in broader investigations of neuromuscular signalling and cellular communication pathways.

Research Applications

Acetyl hexapeptide-3 is investigated within the following approved in-vitro research domains:

• SNAP-25 competitive inhibition studies
• SNARE complex assembly and disassembly research
• Synaptic vesicle exocytosis regulation
• Acetylcholine release and neuromuscular junction signalling
• Wrinkle formation and skin tissue biology research
• Dermatological anti-aging mechanism investigation
• Neurotransmitter release modulation studies
• Cellular communication and signalling pathway research

Reconstitution and Storage

Reconstitute following standard lyophilised peptide protocols appropriate to your research application. Store lyophilised material at −20°C. Once reconstituted, maintain at 4°C and protect from light. Avoid repeated freeze-thaw cycles to preserve peptide integrity.

Explore additional anti-aging and longevity research peptides in our Anti-Age, Longevity and Anti-Age and Healing research categories.

FAQ

What is acetyl hexapeptide-3? Acetyl hexapeptide-3 — also known as Argireline — is a synthetic hexapeptide developed as a competitive inhibitor of SNAP-25, a key component of the SNARE complex involved in synaptic vesicle exocytosis. By disrupting SNARE complex formation, it is hypothesised to reduce acetylcholine release at the neuromuscular junction — the mechanism under investigation in wrinkle formation and skin tissue biology research. Supplied as a 200mg lyophilised powder with >99% purity for in-vitro scientific research.

What is the difference between acetyl hexapeptide 3 and Argireline? Acetyl hexapeptide 3 and Argireline refer to the same compound — Argireline is the trade name under which this synthetic SNAP-25 inhibitor peptide has been commercially referenced, particularly in cosmetic research contexts. Both designations describe an identical molecular structure researched for neuromuscular signalling modulation and wrinkle biology.

How does acetyl hexapeptide-3 inhibit SNAP-25? Acetyl hexapeptide-3 inhibits SNAP-25 through competitive inhibition based on structural mimicry. The amino acid sequence of the peptide shares similarity with the N-terminal domain of SNAP-25 — allowing it to compete for incorporation into the SNARE complex. By occupying the SNAP-25 binding site in the SNARE architecture, the peptide prevents proper SNARE complex formation and impairs the downstream calcium-dependent exocytosis of neurotransmitters including acetylcholine.

What is the SNARE complex and why is it relevant to this research? The SNARE complex is a molecular machine composed of SNAP-25, syntaxin and VAMP/synaptobrevin that mediates synaptic vesicle fusion and neurotransmitter release at the neuromuscular junction. Its calcium-dependent exocytosis function is central to nerve-muscle communication and muscle contraction. Acetyl hexapeptide-3 targets SNAP-25 within this complex — making SNARE biology directly relevant to understanding the compound’s proposed mechanism and its investigation in wrinkle formation research.

What research applications is acetyl hexapeptide-3 used for? Acetyl hexapeptide-3 is used in approved in-vitro research examining SNAP-25 competitive inhibition, SNARE complex assembly dynamics, synaptic vesicle exocytosis regulation, acetylcholine release modulation, neuromuscular signalling pathways and dermatological wrinkle formation mechanisms. All applications are within approved in-vitro research frameworks. This compound is not approved for human administration or cosmetic use.